Background-Chronic kidney disease (CKD) promotes the development of atherosclerosis and increases the risk of cardiovascular disease. The aim of the present study was to compare the coronary plaque characteristics of patients with and without CKD using optical coherence tomography.
T he impact of chronic kidney disease (CKD) on cardio vascular and allcause mortality has been well established. [1] [2] [3] It has been reported that renal function deterioration increases the risk of not only the new onset of acute coronary syndrome (ACS) 1-3 but also the major adverse clinical events during and after percutaneous coronary intervention. 4, 5 Although the underlying pathophysiology is probably related to plaque type, the plaque characteristics of CKD patients have not been clearly identified. Pathology studies have demonstrated that coronary atherosclerosis and calcification were more frequent and advanced in patients with CKD compared with nonCKD patients. 6, 7 A subgroup analysis of the Providing Regional Observation to Study Predictors of Events in the Coronary Tree (PROSPECT) study showed that CKD patients had a larger plaque burden, a greater necrotic core, and dense calcium in their nonculprit lesions. 8 The underlying mechanism for poor outcomes and high recurrent ischemic events in CKD patients has not been fully elucidated. In vivo coronary plaque characteristics in CKD patients may help us to understand the underlying pathophysiology. Optical coherence tomography (OCT) is a highresolution intravascular imaging modality that allows a detailed assessment of coronary plaque morphology. The aim of the present study was to characterize the nonculprit plaques in patients with kidney disease.
Methods

Study Population
The MGH OCT Registry is an ongoing multicenter registry of pa tients who have had OCT imaging during their coronary catheter ization and includes subjects from 20 sites across 6 countries. 9, 10 Between August 2010 and September 2011, 912 subjects were en rolled in the registry. Among these, 53 subjects (5.8%) were excluded because of poor image quality. Plaques were identified when the di ameter stenosis was >30% by OCT as compared with the reference vessel. We did not identify any native coronary artery plaques in 485 subjects (390 subjects had only poststent images, and 95 subjects had only stent restenosis lesion imaging). An additional 5 subjects were excluded because they were already on hemodialysis. On the basis of angiograms, any plaque treated by percutaneous coronary interven tion was defined as a culprit plaque and was excluded. All culprit lesions were identified by the operators using a combination of ECG findings, left ventricular wall motion abnormalities, scintigraphic de fects, and angiographic lesion morphology. Eightytwo subjects were excluded because of the acquired OCT images only containing the culprit plaque. Therefore, the final analysis included the remaining 287 subjects with 463 nonculprit plaques ( Figure 1 ).
The exact location of the OCT catheter identified as the OCT pullback was recorded simultaneously with contrast injection. Coregistration of plaques on both OCT images and angiograms was performed using fiduciary landmarks such as side branches or im planted stents. All plaques were divided into coronary artery surgery segment groups for plaque identification. Plaque analysis was per formed in each segment. Each plaque was separated at least 5 mm from the edge of another plaque or from an implanted stent edge as seen on the longitudinal OCT pullback. Any plaque continuous to an implanted stent was excluded. The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation: eGFR (mL/min per 1.73 m 2 )=175×(S cr ) −1.154 ×(age) −0.203 ×0.742 (if female)×1.210 (if black), and CKD was defined as an eGFR <60 mL/min per 1.73 m 2 . 11 The registry was approved by each site's institutional review board, and all patients provided informed consent.
Acquisition of OCT Images
Images were acquired using a commercially available frequency do main (C7XR OCT Intravascular Imaging System, St. Jude Medical, St. Paul, MN) or time domain (M2/M3 Cardiology Imaging System, LightLab Imaging, Inc, Westford, MA) OCT system. The intracoro nary OCT imaging technique has been described previously. 10 In brief, in the frequency domain OCT system, a 2.7F OCT imaging catheter (Dragonfly, LightLab Imaging, Inc) is advanced distal to the lesion, and automated pullback is initiated in concordance with blood clearance by the injection of contrast media or Dextran. In the time domain OCT system, an occlusion balloon (Helios, LightLab Imaging, Inc) is inflated proximal to the lesion at 0.4 to 0.6 atm dur ing image acquisition. The imaging wire is automatically pulled back from a distal to a proximal position at a rate of 1.0 to 3.0 mm/s, and saline is continuously infused from the tip of the occlusion balloon. The frequency domain OCT system was used in 22.6% of nonCKD patients and 29.5% of CKD patients (P=0.258). All images were dei dentified and digitally stored.
OCT Data Analysis
Plaques were classified into 2 categories: (1) fibrous (homogeneous, high backscattering region) or (2) lipid (lowsignal region with dif fuse border). [12] [13] [14] When lipid was present in ≥90° in any of the crosssectional images within the plaque, it was considered to be a lipidrich plaque. [14] [15] [16] [17] In lipidrich plaques, the lipid arc was measured on the crosssectional view at 1mm intervals over the entire length, and the values were averaged. Lipid length was also measured on a longitudinal view. Lipid index was defined as the mean lipid arc multiplied by lipid length. 10 The fibrous cap thickness of a lipidrich plaque was measured 3 times at its thinnest part, and the average val ue was calculated ( Figure 2 ). 10 Thincap fibroatheroma was defined as a lipidrich plaque with fibrous cap thickness ≤65 μm at the thin nest part on a crosssectional image. 18 Calcification was also recorded when an area showed a signalpoor or heterogeneous region with a sharply delineated border ( Figure 3A ). 12, 18 Macrophage accumula tions were defined as signalrich, distinct, or confluent punctuate re gions that exceeded the intensity of background speckle noise ( Figure  3B ). [18] [19] [20] Cholesterol crystals were defined as thin, linear regions of high intensity within the plaque ( Figure 3C ). 18 Microchannels were defined as signalpoor voids that were sharply delineated in multiple contiguous frames ( Figure 3D ). 12, 18, 21 Plaque disruption was identi fied by the presence of fibrous cap discontinuity with a clear cavity formation inside the plaque. 12, 14 Intracoronary thrombus was defined as a mass (diameter ≥250 μm) attached to the luminal surface or float ing within the lumen, including red (red blood cell-rich) thrombus, which showed high backscattering with high attenuation (resem bling blood) ( Figure 3E ), and white (plateletrich) thrombus, which showed less backscattering, was homogeneous and had low attenu ation ( Figure 3F ). 12, 14, 18, 22 Calcification, macrophage accumulations, cholesterol crystals, microchannels, plaque disruption, and thrombus were recorded only for their presence. The OCT data were analyzed using proprietary software (LightLab Imaging, Inc) at an indepen dent MGH OCT core laboratory by 2 experienced investigators who were blinded to the angiographic and clinical findings. When there was discordance between the investigators, a consensus reading was obtained from a third independent reviewer. The intraclass correla tion coefficients for interobserver and intraobserver reliabilities of the lipid arc were 0.892 and 0.934, respectively. The estimated interob server and intraobserver κ coefficients for cholesterol crystals were 0.810 and 0.933, respectively.
Clinical Follow-up
In the MGH OCT Registry, subjects are followed up at 6 months and then annually thereafter for 5 years. When a clinical event is iden tified, detailed data are collected at the study site and entered into the database. Clinical events include death resulting from any cause, myocardial infarction, any form of revascularization, ischemic cere brovascular events, and any bleeding complications.
Statistical Analysis
All statistical analyses were performed by an independent statisti cian at a core laboratory. Categorical variables are presented as counts and proportions, and the comparisons were performed using a χ 2 test or Fisher exact test, depending on the data. The continuous variables are presented as mean±SD, and if necessary, median and 25th to 75th percentile are also presented. In the present study, 39 (15.6%) subjects had ≥3 plaques. The generalized estimating equa tions was used to take into count the withinsubject correlation for the analysis of multiple plaques within a single patient. The mean values of the continuous measurements between the 2 groups were compared using generalized estimating equations with identity link and exchangeable correlation. For comparisons of betweengroup differences in the rates of dichotomous plaque characteristics, the analysis was performed using generalized estimating equations with logit link and exchangeable correlation structure. Univariate and multivariate linear regression models, including all patients and plaques, were fit to assess the relationship between lipid index and other factors for which the inference was carried out using general ized estimating equations with identity link and exchangeable cor relation structure. Intraobserver and interobserver reliabilities were estimated by means of a κ coefficient for binary outcomes and an
Lipid Index = Mean Lipid Arc × Lipid Length
Fibrous Cap Measurement Figure 2 . Optical coherence tomography measurement. In lipid-rich plaques, the lipid arc was measured at 1-mm intervals over the entire length, and the values were averaged. Lipid length was also measured on a longitudinal view. Lipid index was defined as the mean lipid arc multiplied by lipid length. The fibrous cap thickness of a lipid-rich plaque was measured 3 times at its thinnest part, and the average value was calculated. intraclass correlation coefficient for continuous measurements. There were no type 1 error rate controls for multiple statistical com parisons because of the exploratory nature of the analyses, and a value of P<0.05 from 2sided test was considered to be statistically significant. All analyses were performed using IBM SPSS software version 19.0 (SPSS Inc, Chicago, IL). Table 1 shows baseline patient demographics. The nonCKD group consisted of 250 subjects and the CKD group of 37 subjects. The CKD group was older, had a lower level of hemoglobin, and had a higher use of angiotensinconverting enzyme inhibitor/angiotensin II receptor blocker.
Results
Baseline Patient Demographics
Baseline Plaque Characteristics
A total of 463 nonculprit plaques were detected in 287 sub jects: 402 plaques in the nonCKD group (1.6 plaques per patient) and 61 plaques in the CKD group (1.6 plaques per patient). The distribution of plaques in the 3 coronary arteries is shown in Table 2 : 35.2% of plaques were located in the right coronary artery, 42.1% in the left anterior descending artery, and 22.7% in the left circumflex. This distribution did not dif fer between the groups. Although the reference diameter and area were not significantly different, the minimum area was smaller and the percentage diameter stenosis was greater in CKD patients than in nonCKD patients.
OCT Findings
Comparisons of quantitative OCT findings between nonCKD and CKD are shown in Figure 4 . Figure 5 . The prevalence of lipidrich plaques was similar between the groups, as was the prevalence of macrophage accumulations, microchannels, and thincap fibroatheroma. However, calcification, cholesterol crystals, and disruption were more frequently observed and thrombus tended to be more frequent in the CKD group. Although the baseline patient characteristics were different between the nonCKD and CKD groups, quantitative and qualitative OCT findings were not adjusted for other factors because the primary purpose was to make a direct comparative description of the plaque characteristics. No correlation between eGFR and lipid index was observed (P=0.102; r=0.061; Figure 6 ). 
Univariate and Multivariate Linear Regression Models for Lipid Index
Clinical Follow-up Data
The 1year followup rate was 96.5%. Thirteen patients (4.5%) had clinical events: 1 (0.3%) noncardiac death, 10 (3.5%) percutaneous coronary interventions, and 2 coronary artery bypass grafts (0.7%). Only 1 patient with CKD underwent per cutaneous coronary intervention during the followup period.
Discussion
The present study demonstrated that nonculprit plaques in patients with CKD had a larger lipid index as compared with nonCKD patients. The presence of calcification, cholesterol crystals, and disruption was more frequently observed in CKD patients. The multivariate linear regression model demonstrated that a lower eGFR and diabetes mellitus were independently associated with a larger lipid index.
Plaque Characteristics in CKD Patients
CKD is recognized as an independent risk factor for cardio vascular events, including ACS. [1] [2] [3] A previous postmortem study demonstrated that a lower eGFR level is associated with a greater percentage of advanced coronary atheroscle rosis, defined as American Heart Association types IV to VI. 7 Moreover, integrated backscatter intravascular ultrasound studies demonstrated that a lower eGFR level is related to a higher percentage of lipid volume and a lower percentage of fibrous volume. 23, 24 In the present study, plaques in CKD patients had a wider lipid arc, a longer lipid length, and a larger lipid index. Although a correlation between eGFR and lipid index was not observed, the multivariate linear regres sion model demonstrated that a lower eGFR was an indepen dent risk factor for a larger lipid index after adjustment for other factors.
In the present study, the prevalence of thincap fibroath eroma and macrophage accumulations did not differ between the groups. The subgroup analysis of the PROSPECT study also demonstrated that the prevalence of Virtual Histology derived thincap fibroatheroma was not significantly different, Non-CKD CKD Figure 5 . Qualitative optical coherence tomography findings. Compared to nonchronic kidney disease (CKD) plaques, plaques with CKD had a higher prevalence of calcification, cholesterol crystals, and disruption. Thrombus tended to be more frequently observed in the CKD group. TCFA indicates thin-cap fibroatheroma.
although plaques in CKD patients had a higher plaque burden with a greater necrotic core and a higher frequency of dense calcium. 8 Nonculprit plaques were selected because it is often chal lenging to acquire optimalquality images in the presence of luminal thrombus and severe stenosis. In that case, opera tors may be more likely to perform OCT after predilatation or stenting. In the registry database, culprit lesion images of optimal quality were acquired in 36.8% of ACS patients and in 59.7% of nonACS patients. However, several studies have shown that nonculprit lesions have morphological char acteristics similar to culprit lesions as detected by angiogra phy, 25 intravascular ultrasound, 26 angioscopy, 27 and coronary thermography. 28, 29 
Calcification and Cholesterol Crystals
We identified several differences in coronary atherosclerotic plaque composition between patients with and without CKD. The prevalence of calcification and cholesterol crystals was higher in CKD patients as compared with nonCKD patients. In previous autopsy, 6,7 intravascular ultrasound, 8 and com puted tomography angiography 30, 31 studies, calcification was more frequently observed in plaques of CKD patients com pared with those in nonCKD. It has been reported that the uremic state is associated with numerous metabolic abnormal ities and endocrine disturbances, including abnormalities in calcium, phosphate metabolism, and inflammatory syndrome. These dysfunctions occur early in the course of CKD and con tribute to the development and progression of vascular calcifi cation and atherosclerosis. 32 Cholesterol crystals play an important role in the athero sclerotic process 33 and serve as a marker for advanced ath erosclerotic lesions. 34 On OCT images, cholesterol crystals are observed as thin, linear lesions of high intensity, usually associated with lipidrich plaque. A previous autopsy study demonstrated that there were strong associations between cholesterol crystals and plaque disruption, thrombus, and plaque size; moreover, cholesterol crystals were significantly associated with clinical events. 35 In the present study, choles terol crystals were more frequently observed in plaques of CKD patients compared with those of nonCKD. The present results also suggest that CKD patients have advanced plaques in their coronary trees.
Disruption and Thrombus
In the present study, the prevalence of disruption in noncul prit plaques was higher in the CKD group as compared with the nonCKD group, and thrombus tended to be more fre quent in the CKD group. Plaque disruption exposes throm bogenic substrates to circulating blood, leading to local thrombus formation. When thrombus is not occlusive, the disruption can be silent without causing ischemia or myo cardial necrosis. The thrombus will then be organized, result ing in sudden plaque growth. A pathological study showed evidence of multiple plaque ruptures before a clinical event, indicating that the majority of plaque disruptions are silent. 36 Several intracoronary imaging studies have reported that plaque rupture was observed not only in the culprit lesion but also in nonculprit sites. A 3vessel OCT study demonstrated that 35.3% of ACS patients and 12.6% of nonACS patients had disruption in nonculprit lesions 10 ; a 3vessel intravascular ultrasound study reported 8% of ACS plaques and 4% non ACS plaques. 37 Tanaka et al 38 reported that multiple plaque disruption was associated with systemic inflammation and that patients with multiple plaque rupture had poor progno ses. Although plaque disruption with thrombus formation is thought to be the main underlying mechanism of ACS, the significance of disruption and thrombus on OCT in CKD patients is still unknown. To the best of our knowledge, our study is the first to demonstrate the prevalence of plaque dis ruption and thrombus in CKD plaques; further investigation, including the clinical significance of plaque disruption and thrombus, is warranted. Patients with CKD are more likely to die of cardiovascular disease than to require dialysis. 39 Therefore, reduction of mor bidity and mortality in patients with CKD requires strict man agement of these patients' cardiovascular disease risk factors. The National Kidney Foundation's Kidney Disease Outcome Quality Initiative guidelines recommend an A 1c level of <7% with diabetes mellitus, 40 a blood pressure goal of <130/80 mm Hg, 41 and lowdensity lipoproteincholesterol levels <100 mg/dL. 42 All of these recommendations are related to anti atherosclerosis effects. In the present study, plaques in CKD patients had a larger lipid index. Moreover, the multivariate linear regression model demonstrated that a lower eGFR was an independent risk factor for a larger lipid index. We could not find any relationship between lipid data and followup clinical events; it is possible that this lack of relationship is related to the small number of subjects and short followup period. However, aggressive lipid management would prob ably have an additional value in CKD patients.
Limitations
First, patients in this registry were selected for OCT by the operator, introducing the possibility of selection bias. Second, exact measurements of necrotic core and plaque burden by OCT are not possible because of the relatively shallow axial penetration. Third, calcification, macrophage accumulations, cholesterol crystals, microchannel, disruption, and thrombus were not quantified or rigorously validated. Fourth, although the baseline patient characteristics were different between patients with and without CKD, quantitative and qualitative OCT findings were not adjusted for other factors because the primary purpose was to make a direct comparative description of the plaque characteristics. Fifth, the sample size for this study was limited, especially with regard to the small number of CKD patients. Sixth, OCT imaging did not include whole coronary artery segments. Seventh, the duration of CKD has been linked with poor outcomes and affected plaque morphol ogy; however, the patientreported duration of CKD was not collected in the registry. Eighth, the very proximal segment was not visualized because of the proximal occlusion balloon when the time domain OCT system was used. Although 2 OCT systems were used (frequency domain and time domain OCT system) in the present study, the percentage of imaged plaques by each modality and the plaque distribution were not significantly different between the CKD and nonCKD groups. Ninth, 5 patients on hemodialysis (8 plaques) were not included because of the small number. Tenth, the culprit lesions were identified by the operators at each site. Finally, we collected data only from nonculprit plaques.
Conclusions
Compared with nonCKD patients, patients with CKD had a larger lipid index and a higher prevalence of calcium, cho lesterol crystals, and disruption. Thrombus tended to be more frequently observed in the CKD group. Multivariate linear regression model demonstrated that a lower eGFR was an independent risk factor for a larger lipid index.
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